Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.07

+0.9%

Nov 12 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (178)	1/8/2003 1:35:53 PM
From: Jibacoa	Read Replies (2) of 3722

LJPC It has been up to 14% earlier today (only 11.66% at present with volume more than 2x its daily average. The company's Phase III trial on Riquent was completed in December, but it said then that it had to "compile and audit the data from the trial sites " prior to "the unblinding and analysis of results", which it expected to have ready for a report "as early as February 2003". LJPC has now an on-going open-label trial, which is designed to collect longer-term safety data.(Eligible patients which already completed its Phase III, will receive weekly treatment with Riquent). LJPC is one of the companies staying on the black column in an otherwise downward Biotech market. (The BTK is down from yesterday's close of 349.25 to 342.72 at present. LJPC shares are trading today above its November 29 H of 7.05 but still below its January 11,2002 H of 9.42 The March 2000 H at 12.25 is a little farther away.<g> siliconinvestor.com siliconinvestor.com bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next